Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

3DCC

Financiado

Cerrado

Ready to use 3D Cell Cultures for early de risking in drug development

StemTek is a global biopharmaceutical company with a clear stem cell focus in drug development for cancer treatment. Only about 10% of the candidate compounds progress successfully through clinical development. Many drugs fail dur... ver más

30/04/2017

STEMTEK THERAPEUTI...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

STEMTEK THERAPEUTICS La investigacion de principios y productos referidos a especialidades farmaceuticas de todas clases

TRL 3-4 | 130K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-04-30

SMEInst-05-2016-2017: Supporting innovative SMEs in the h...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

STEMTEK THERAPEUTICS

50.00K€ | Lider

Proyectos interesantes

DifMATRIX

Medical Technol...

Biotechnology

71K€ Cerrado

3DProSeed

Medical Technol...

Biotechnology

71K€ Cerrado

PDC2022-133826-I00

Medical Technol...

Biotechnology

115K€ Cerrado

META-CHIP

Medical Technol...

Biotechnology

1M€ Cerrado

HOLOCELL

Medical Technol...

Biotechnology

150K€ Cerrado

UNA NOVEDOSA PLATAFORMA DE TAMIZAJE AVANZADO...

Medical Technol...

Biotechnology

1M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 4 meses Fecha Inicio: 2016-12-07
Fecha Fin: 2017-04-30

Líder del proyecto

STEMTEK THERAPEUTICS La investigacion de principios y productos referidos a especialidades farmaceuticas de todas clases

TRL 3-4 | 130K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto StemTek is a global biopharmaceutical company with a clear stem cell focus in drug development for cancer treatment. Only about 10% of the candidate compounds progress successfully through clinical development. Many drugs fail during clinical trials, especially during phase III, which is the most expensive phase of clinical development, largely due to the lack of clinical efficacy and/or unacceptable toxicity. StemTek is developing a solution to make cell based assays a commodity: easy to get, easy to buy, easy to use, and disposable, so we eliminate the need for large tissue culture facilities. This new solution is a ready-to-use 3D spheroid culture in standard 96 well plate format that allows customers to profile their pipeline of compounds for their effect on CSC populations using 3D culture models. Thanks to the 3DCC, a business opportunity appears to develop a multi-million euro business capitalizing on the thriving interest from Pharma in finding novel biological testing systems based on 3D cell culture. Latest Markets&market report (2016) establishes that the global 3D cell culture market is expected to reach USD 1,345.2 M by 2021 from USD 466.8 M in 2016 at a CAGR of 23.6% (market growth). According to BCC research, from the seven different niches, Reagents, media and sera is precisely the most relevant (37.2 %). 3DCC objectives are: • To produce tailor made kits to improve compatibility with different drug development programs, leading to a broad range of applications. • To use all the competitive advantages of CSC enriched 3D spheroid cultures in ready to use standard 96 well plate format. • The large-scale production of ready to use kits to be able to enter/supply the pharmaceutical industry to achieve economies of scale, and go from current 800 kits/year (manually) up to 120.000 kits per year. • The integration of CSC testing into the drug development strategy of top 10 Big Pharma companies.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores